GB9927320D0 - Exosome separation - Google Patents

Exosome separation

Info

Publication number
GB9927320D0
GB9927320D0 GBGB9927320.3A GB9927320A GB9927320D0 GB 9927320 D0 GB9927320 D0 GB 9927320D0 GB 9927320 A GB9927320 A GB 9927320A GB 9927320 D0 GB9927320 D0 GB 9927320D0
Authority
GB
United Kingdom
Prior art keywords
exosome separation
hepatitis
virus
separation
exosome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9927320.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GSK Vaccines SRL
Original Assignee
Chiron SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron SRL filed Critical Chiron SRL
Priority to GBGB9927320.3A priority Critical patent/GB9927320D0/en
Publication of GB9927320D0 publication Critical patent/GB9927320D0/en
Priority to DE60036403T priority patent/DE60036403T2/de
Priority to AT00979837T priority patent/ATE373084T1/de
Priority to JP2001538480A priority patent/JP4675017B2/ja
Priority to DK00979837T priority patent/DK1230347T3/da
Priority to PT00979837T priority patent/PT1230347E/pt
Priority to US10/130,467 priority patent/US7198923B1/en
Priority to AU17218/01A priority patent/AU1721801A/en
Priority to EP00979837A priority patent/EP1230347B1/en
Priority to CA2392075A priority patent/CA2392075C/en
Priority to ES00979837T priority patent/ES2292489T3/es
Priority to PCT/IB2000/001801 priority patent/WO2001036601A1/en
Priority to US11/699,925 priority patent/US7807438B2/en
Priority to CY20071101559T priority patent/CY1107521T1/el
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24251—Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GBGB9927320.3A 1999-11-18 1999-11-18 Exosome separation Ceased GB9927320D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GBGB9927320.3A GB9927320D0 (en) 1999-11-18 1999-11-18 Exosome separation
PCT/IB2000/001801 WO2001036601A1 (en) 1999-11-18 2000-11-20 Method for the preparation of purified hcv rna by exosome separation
US10/130,467 US7198923B1 (en) 1999-11-18 2000-11-20 Method for the preparation of purified HCV RNA by exosome separation
EP00979837A EP1230347B1 (en) 1999-11-18 2000-11-20 Method for the preparation of purified hcv rna by exosome separation
JP2001538480A JP4675017B2 (ja) 1999-11-18 2000-11-20 エキソソーム分離によって精製ｈｃｖｒｎａを調製するための方法
DK00979837T DK1230347T3 (da) 1999-11-18 2000-11-20 Fremgangsmåde til fremstilling af oprenset HCV-RNA ved exosomseparering
PT00979837T PT1230347E (pt) 1999-11-18 2000-11-20 Método de preparação de rna do hcv purificado por separação de exossomas
DE60036403T DE60036403T2 (de) 1999-11-18 2000-11-20 Verfahren zur Herstellung von gereinigter HCV-RNA durch Isolierung von Exosomen
AU17218/01A AU1721801A (en) 1999-11-18 2000-11-20 Method for the preparation of purified hcv rna by exosome separation
AT00979837T ATE373084T1 (de) 1999-11-18 2000-11-20 Verfahren zur herstellung von gereinigtem hcv rna durch isolierung von exosomen
CA2392075A CA2392075C (en) 1999-11-18 2000-11-20 Method for the preparation of purified hcv rna by exosome separation
ES00979837T ES2292489T3 (es) 1999-11-18 2000-11-20 Procedimiento para la preparacion de arn de vhc purificado por separacion de exosomas.
US11/699,925 US7807438B2 (en) 1999-11-18 2007-01-30 Preparation of purified exosomes comprising HCV RNA
CY20071101559T CY1107521T1 (el) 1999-11-18 2007-12-07 Μεθοδος για την παρασκευη καθαρισμενου hcv rna με διαχωρισμο εξωσωματων

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9927320.3A GB9927320D0 (en) 1999-11-18 1999-11-18 Exosome separation

Publications (1)

Publication Number Publication Date
GB9927320D0 true GB9927320D0 (en) 2000-01-12

Family

ID=10864765

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9927320.3A Ceased GB9927320D0 (en) 1999-11-18 1999-11-18 Exosome separation

Country Status (13)

Country Link
US (2) US7198923B1 (enExample)
EP (1) EP1230347B1 (enExample)
JP (1) JP4675017B2 (enExample)
AT (1) ATE373084T1 (enExample)
AU (1) AU1721801A (enExample)
CA (1) CA2392075C (enExample)
CY (1) CY1107521T1 (enExample)
DE (1) DE60036403T2 (enExample)
DK (1) DK1230347T3 (enExample)
ES (1) ES2292489T3 (enExample)
GB (1) GB9927320D0 (enExample)
PT (1) PT1230347E (enExample)
WO (1) WO2001036601A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110123841A (zh) * 2018-02-09 2019-08-16 上海市第六人民医院 负载白藜芦醇的人多能干细胞外泌体在制备治疗生殖系统疾病药物的用途
CN110123838A (zh) * 2018-02-02 2019-08-16 上海睿泰生物科技股份有限公司 负载白藜芦醇的人多能干细胞外泌体及其制备方法与用途

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9927320D0 (en) * 1999-11-18 2000-01-12 Chiron Spa Exosome separation
US8021847B2 (en) 2004-06-02 2011-09-20 Proxy Life Science Holdings, Inc. Microvesicle-based compositions and methods
WO2005121369A2 (en) * 2004-06-02 2005-12-22 Sourcepharm, Inc. Rna-containing microvesicles and methods therefor
ES2880460T3 (es) * 2006-03-09 2021-11-24 Aethlon Medical Inc Eliminación extracorpórea de partículas microvesiculares
US9085778B2 (en) * 2006-05-03 2015-07-21 VL27, Inc. Exosome transfer of nucleic acids to cells
US8617806B2 (en) * 2008-01-25 2013-12-31 Hansabiomed Ou Method to measure and characterize microvesicles in the human body fluids
AU2009212543B2 (en) * 2008-02-01 2015-07-09 The General Hospital Corporation Use of microvesicles in diagnosis, prognosis and treatment of medical diseases and conditions
US11266736B2 (en) 2008-04-17 2022-03-08 Vin De Bona Trading Company Pte Ltd Method of painting micro vesicles
AU2009259893A1 (en) * 2008-06-20 2009-12-23 Proxy Life Science Holdings, Inc. Microvesicle-based compositions and methods
US9487837B2 (en) 2008-10-06 2016-11-08 Morehouse School Of Medicine Exosome-mediated diagnosis of hepatitis virus infections and diseases
US10545149B2 (en) * 2008-10-06 2020-01-28 Morehouse School Of Medicine Detection of HIV-related proteins in urine
JP2012507300A (ja) 2008-10-30 2012-03-29 カリス ライフ サイエンシズ ルクセンブルク ホールディングス Ｒｎａパターンを評価する方法
EP2350320A4 (en) * 2008-11-12 2012-11-14 Caris Life Sciences Luxembourg Holdings METHOD AND SYSTEMS FOR USE OF EXOSOMES FOR THE DETERMINATION OF PHENOTYPES
PT2419144T (pt) * 2009-04-17 2019-09-16 Univ Oxford Innovation Ltd Composição para a administração de material genético
BRPI0900815A2 (pt) * 2009-04-23 2010-12-28 Sociedade Benef Israelita Bras Hospital Albert Einstein método para isolamento de exossomos a partir de soluções biológicas utilizando nanopartìculas de óxido de ferro
DK2454588T3 (en) 2009-07-16 2015-09-28 Gen Hospital Corp Nucleic acid
EP2475988B1 (en) 2009-09-09 2018-11-14 The General Hospital Corporation Use of microvesicles in analyzing nucleic acid profiles
US20130029339A1 (en) 2009-09-09 2013-01-31 The General Hospital Corporation Use of microvesicles in analyzing kras mutations
WO2011049059A1 (ja) * 2009-10-22 2011-04-28 国立大学法人岐阜大学 Ｒｎａ内包キャリア組成物
CA2782284A1 (en) 2009-11-30 2011-06-03 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Methods and systems for isolating, storing, and analyzing vesicles
AU2011223789A1 (en) 2010-03-01 2012-09-20 Caris Life Sciences Switzerland Holdings Gmbh Biomarkers for theranostics
KR20130043104A (ko) 2010-04-06 2013-04-29 카리스 라이프 사이언스 룩셈부르크 홀딩스 질병용 순환 생물학적 지표들
JP5755326B2 (ja) 2010-06-11 2015-07-29 日立化成株式会社 腎機能の特徴を決定する方法
WO2011156734A2 (en) * 2010-06-11 2011-12-15 Hitachi Chemical Co., Ltd. Method of characterizing vascular diseases
WO2012006476A2 (en) 2010-07-07 2012-01-12 Aethlon Medical, Inc. Methods and compositions for quantifying exosomes
WO2012031008A2 (en) 2010-08-31 2012-03-08 The General Hospital Corporation Cancer-related biological materials in microvesicles
CA2817111C (en) 2010-11-10 2019-03-05 Exosome Diagnostics, Inc. Method for isolation of nucleic acid containing particles and extraction of nucleic acids therefrom
CA2835641C (en) 2011-05-11 2019-05-28 Exosome Diagnostics, Inc. Nucleic acid extraction from heterogeneous biological materials
WO2012170037A1 (en) 2011-06-10 2012-12-13 Hitachi Chemical Co., Ltd. Vesicle capturing devices and methods for using same
CA2839896A1 (en) 2011-06-21 2012-12-27 Alnylam Pharmaceuticals, Inc. Assays and methods for determining activity of a therapeutic agent in a subject
EP3492606B1 (en) 2011-08-22 2023-10-04 Exosome Diagnostics, Inc. Urine biomarkers
KR20140076571A (ko) * 2011-09-22 2014-06-20 유니버시다드 데 로스 안데스 급성 신장 손상의 조기 모니터링, 진단 및/또는 예후 방법
EP2776587A4 (en) 2011-11-10 2015-07-15 Exosome Diagnostics Inc LIQUOR ASSAY
GB201121070D0 (en) 2011-12-07 2012-01-18 Isis Innovation composition for delivery of biotherapeutics
EP3299814A3 (en) * 2012-07-19 2018-04-11 Atlantic Cancer Research Institute Method for the isolation of microvesicles
US11136627B2 (en) 2012-08-30 2021-10-05 Exosome Diagnostics, Inc. Controls for nucleic acid assays
US20150252428A1 (en) 2012-10-03 2015-09-10 Exosome Diagnostics, Inc. Use of microvesicles in diagnosis, prognosis, and treatment of medical diseases and conditions
US20150233800A1 (en) 2012-10-11 2015-08-20 Vin-De-Bona Trading Company Pte Ltd Method of painting microvesicles
US10942184B2 (en) 2012-10-23 2021-03-09 Caris Science, Inc. Aptamers and uses thereof
BR112015016136A2 (pt) 2013-01-03 2017-07-11 Exosome Diagnostics Inc métodos para isolar microvesículas
US12558316B2 (en) 2013-03-13 2026-02-24 University Of Miami Methods and compositions for the treatment of epidermolysis bullosa
AU2014244618A1 (en) 2013-03-13 2015-10-08 University Of Miami Method for isolation and purification of microvesicles from cell culture supernatants and biological fluids
WO2014182330A1 (en) 2013-05-06 2014-11-13 Hitachi Chemical Company Ltd Devices and methods for capturing target molecules
CA2920429C (en) 2013-08-06 2021-11-16 Exosome Diagnostics, Inc. Urine biomarker cohorts, gene expression signatures, and methods of use thereof
BR112016004153A2 (pt) 2013-08-28 2019-09-17 Caris Life Sciences Switzerland Holdings Gmbh "método para caracterizar uma doença ou distúrbio, kit, composição, método para gerar uma biblioteca de entrada, oligonucleotídeo, pluralidade de oligonucleotídeos e método para identificar um aptâmero
US9958460B2 (en) * 2013-10-24 2018-05-01 Nanosomix, Inc. Biomarkers and diagnostic methods for Alzheimer's disease and other neurodegenerative disorders
EP3517959B1 (en) * 2014-01-21 2021-05-05 Morehouse School of Medicine Exosome-mediated detection of hepatitis c infections
WO2015153732A2 (en) 2014-04-01 2015-10-08 Cornell University Use of double-stranded dna in exosomes: a novel biomarker in cancer detection
US11268085B2 (en) 2014-05-27 2022-03-08 Exosome Diagnostics, Inc. Methods for isolating microvesicles and extracting nucleic acids from biological samples
SG11201700146QA (en) 2014-07-09 2017-02-27 Exosome Diagnostics Inc Methods for isolating microvesicles and extracting nucleic acids from biological samples
US20170227541A1 (en) 2014-07-17 2017-08-10 The Trustees Of The University Of Pennsylvania Methods for using exosomes to monitor transplanted organ status
US10266895B2 (en) 2014-11-05 2019-04-23 Hitachi Chemical Company Ltd. Exosomes and microvesicles in intestinal luminal fluids and stool and use of same for the assessment of inflammatory bowel disease
WO2016077537A1 (en) 2014-11-12 2016-05-19 Hitachi Chemical Co., Ltd. Method and device for diagnosing organ injury
EP3112474A1 (en) 2015-06-29 2017-01-04 Evonik Degussa GmbH Method of detecting avian necrotic enteritis
US20180066262A1 (en) 2015-03-09 2018-03-08 Caris Science, Inc. Oligonucleotide probes and uses thereof
EA201890006A1 (ru) 2015-06-10 2018-05-31 Борд Оф Риджентс, Дзе Юниверсити Оф Техас Систем Применение экзосом для лечения болезни
WO2017004243A1 (en) 2015-06-29 2017-01-05 Caris Science, Inc. Therapeutic oligonucleotides
US10941176B2 (en) 2015-07-28 2021-03-09 Caris Science, Inc. Therapeutic oligonucleotides
JP6624704B2 (ja) 2015-08-31 2019-12-25 日立化成株式会社 尿路上皮疾患の評価のための分子法
EP3165926A1 (en) 2015-11-06 2017-05-10 Humanitas Mirasole S.p.A. Method for characterization of cell specific microvesicles
JP2019513391A (ja) 2016-04-15 2019-05-30 エクソサム ダイアグノスティクス，インコーポレイティド 未分化リンパ腫キナーゼ（ａｌｋ）核酸およびａｌｋ融合転写産物の血漿ベースの検出、並びに癌の診断と治療におけるそれらの使用
WO2018057820A1 (en) 2016-09-21 2018-03-29 Predicine, Inc. Systems and methods for combined detection of genetic alterations
WO2017181161A1 (en) 2016-04-15 2017-10-19 Predicine, Inc. Systems and methods for detecting genetic alterations
KR102516168B1 (ko) 2016-05-02 2023-03-30 엔코디아, 인코포레이티드 암호화 핵산을 사용한 거대분자 분석
ES2908932T3 (es) 2016-05-05 2022-05-04 Exosome Diagnostics Inc Perfilado de ácidos nucleicos de microvesícula y usos del mismo como características distintivas en diagnóstico de rechazo de trasplante renal
JP7037504B2 (ja) 2016-05-13 2022-03-16 エクソサム ダイアグノスティクス，インコーポレイティド 生体液からの細胞外小胞の単離及びセルフリーｄｎａの同時単離のための自動及び手動方法
IL247368A0 (en) 2016-08-18 2016-11-30 Yeda Res & Dev Diagnostic and therapeutic uses of exosomes
EP3515453A1 (en) 2016-09-22 2019-07-31 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for reprograming immune environment in a subject in need thereof
US11396676B2 (en) 2016-10-21 2022-07-26 Exosome Diagnostics, Inc. Sequencing and analysis of exosome associated nucleic acids
WO2018102162A1 (en) 2016-11-30 2018-06-07 Exosome Diagnostics, Inc. Methods and compositions to detect mutations in plasma using exosomal rna and cell free dna from non-small cell lung cancer patients
GB2559319B (en) 2016-12-23 2019-01-16 Cs Genetics Ltd Reagents and methods for the analysis of linked nucleic acids
US20200149036A1 (en) 2017-01-02 2020-05-14 Exosome Diagnostics, Inc. Methods to distinguish rna and dna in a combined preparation
ES2944359T3 (es) 2017-05-12 2023-06-20 Evonik Operations Gmbh Procedimiento de detección de enfermedades inducidas por C. perfringens en una bandada de aves
WO2018213392A1 (en) 2017-05-17 2018-11-22 Exosome Diagnostics, Inc. Microvesicle nucleic acids and/or proteins and uses thereof as markers of renal transplant rejection
EP3652315A4 (en) * 2017-07-12 2021-09-01 Exosome Diagnostics, Inc. METHODS FOR ISOLATION AND ENRICHMENT OF EXTRACELLULAR VESICLE POPULATIONS DERIVED FROM BIOFLUIDS, AND ASSOCIATED METHODS OF USE
US11345957B2 (en) 2017-07-18 2022-05-31 Exosome Diagnostics, Inc. Methods of treating glioblastoma in a subject informed by exosomal RNA signatures
MX2020004559A (es) 2017-10-31 2020-10-05 Encodia Inc Kits para análisis utilizando codificación y/o etiqueta de ácido nucleico.
US20200339987A1 (en) 2017-11-09 2020-10-29 Alnylam Pharmaceuticals, Inc. Assays and methods for determining expression of the lect2 gene
KR20200128413A (ko) 2018-03-02 2020-11-12 에보니크 오퍼레이션즈 게엠베하 오보트랜스페린을 결정함으로써 동물에서의 장 장벽 기능상실을 검출하기 위한 시험관내 방법
WO2019236853A1 (en) 2018-06-06 2019-12-12 Exosome Diagnostics, Inc. Methods for developing urine biomarkers and for detecting bladder cancer
EP3884045B1 (en) 2018-11-20 2023-01-11 Exosome Diagnostics, Inc. Methods for internal controls of microvesicle isolations
BR112021011158A2 (pt) 2018-12-14 2021-08-31 Evonik Operations Gmbh Método in vitro para detectar disbiose intestinal aviária, uso do dito método e uso de isoleucil-arginina ou isômeros desta
EP3963070A4 (en) 2019-04-30 2023-02-22 Encodia, Inc. METHODS OF PREPARATION OF ANALYTES AND RELATED KITS
US12493029B2 (en) 2019-09-18 2025-12-09 Exosome Diagnostics, Inc. Compositions, methods, and kits for the isolation of extracellular vesicles
US20230135456A1 (en) 2020-04-13 2023-05-04 Exoprother Medical Ltd. Cell-derived vesicles comprising wild-type p53 protein for antiviral therapy
US20210322483A1 (en) 2020-04-16 2021-10-21 Ichilov Tech Ltd. Cell-derived particles presenting heterologous cd24 and use thereof in therapy
IL277743A (en) 2020-10-01 2022-04-01 Yeda Res & Dev A method for diagnosing breast cancer
TW202214851A (zh) * 2020-10-07 2022-04-16 國立中央大學 外泌體核酸萃取方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT54896A (en) * 1989-03-17 1991-04-29 Chiron Corp Process for producing aquous diagnosticum and vaccine of nanbv
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
JPH05508762A (ja) 1990-04-03 1993-12-09 サウスウエスト・ファウンデイション・フォー・バイオメディカル・リサーチ 精製されたｈｃｖならびにｈｃｖタンパク質およびペプチド
GB9416671D0 (en) 1994-08-17 1994-10-12 Biocine Spa Assay
EP0841945B1 (en) * 1995-08-03 2006-03-08 Rijksuniversiteit te Leiden Cell derived antigen presenting vesicles
GB9517926D0 (en) 1995-09-01 1995-11-01 Biocine Spa Binding protein
FR2766205B1 (fr) 1997-07-16 2002-08-30 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
WO1999018198A1 (en) 1997-10-06 1999-04-15 Chiron S.P.A. Hepatitis c receptor protein cd81
CA2305715A1 (en) * 1997-11-06 1999-05-20 Innogenetics N.V. Host derived proteins binding hcv: medical, diagnostic and purification use
GB9927320D0 (en) * 1999-11-18 2000-01-12 Chiron Spa Exosome separation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110123838A (zh) * 2018-02-02 2019-08-16 上海睿泰生物科技股份有限公司 负载白藜芦醇的人多能干细胞外泌体及其制备方法与用途
CN110123841A (zh) * 2018-02-09 2019-08-16 上海市第六人民医院 负载白藜芦醇的人多能干细胞外泌体在制备治疗生殖系统疾病药物的用途

Also Published As

Publication number Publication date
US7198923B1 (en) 2007-04-03
AU1721801A (en) 2001-05-30
DK1230347T3 (da) 2007-11-05
JP2003514523A (ja) 2003-04-22
JP4675017B2 (ja) 2011-04-20
CA2392075A1 (en) 2001-05-25
CY1107521T1 (el) 2013-03-13
WO2001036601A1 (en) 2001-05-25
US20070254351A1 (en) 2007-11-01
EP1230347B1 (en) 2007-09-12
CA2392075C (en) 2011-01-04
PT1230347E (pt) 2007-12-20
US7807438B2 (en) 2010-10-05
DE60036403T2 (de) 2008-06-12
ATE373084T1 (de) 2007-09-15
DE60036403D1 (de) 2007-10-25
ES2292489T3 (es) 2008-03-16
EP1230347A1 (en) 2002-08-14

Similar Documents

Publication Publication Date Title
AU1721801A (en) Method for the preparation of purified hcv rna by exosome separation
AU4203201A (en) Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequences
WO2002060926A3 (en) Hepatitis c tripeptide inhibitors
AU4358701A (en) Methods of preventing and treating respiratory viral infeciton using immunomodulatory polynucleotide sequences
AU2002360592A8 (en) Inhibitors of hepatitis c virus
AU2055301A (en) Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease
AU6371900A (en) Lactam inhibitors of hepatitis c virus ns3 protease
WO2002030455A3 (de) Mittel zur behandlung von virus-infektionen
HUP0302957A2 (hu) Hepatitis C vírus alkil- és aril-alanin P2 csoportokat tartalmazó makrociklusos NS-3 szerin proteáz inhibitorai
NZ503263A (en) Hepatitis C NS3 protease inhibitor peptides and peptide analogues
AU2001277967A1 (en) Peptides as ns3-serine protease inhibitors of hepatitis c virus
AU2002230763A8 (en) Inhibitors of hepatitis c virus ns3 protease
UA66767C2 (uk) Інгібітори серин-протеаз, фармацевтична композиція, спосіб інгібування активності та спосіб лікування або профілактики вірусної інфекції гепатиту с
HU229997B1 (hu) Új peptidek mint hepatitis C vírus NS3-szerin-proteáz inhibitorok
WO2005028496A3 (en) Vaccine for treatment and prevention of herpes simplex virus infection
WO2003015708A3 (en) Composition and method for treating hiv infection
MXPA03006971A (es) Tratamiento del virus de hepatitis b.
AUPP971399A0 (en) Separation of plasma components
WO2004089983A3 (en) Severe acute respiratory syndrome (sars) causing coronavirus
EP1141255A4 (en) MODIFIED FORMS OF HEPATITIS C VIRUS NS3 PROTEASE
ATE236999T1 (de) Verfahren zur reinigung bzw. isolierung viraler nukleinsäuren
WO2001017537A3 (en) Methods and compositions for reducing immune response
WO2003053332A3 (en) Composition and method for treating viral infection
PH31116A (en) Methods for the treatment of infection caused by hepatitis B virus (hbv).
AU2001269092A1 (en) Inhibitors of hepatitis b virus infection

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)